Literature DB >> 3663462

Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation.

H Barr1, C J Tralau, A J MacRobert, N Krasner, P B Boulos, C G Clark, S G Bown.   

Abstract

Photodynamic therapy (PDT) involves the interaction of light with an administered photosensitising agent to produce cellular destruction. It has promising potential for the local and endoscopic treatment of gastrointestinal cancer. There is however little data on the response of normal intestine to PDT. We have investigated the use of a new photosensitiser chloro aluminum sulphonated phthalocyanine (AlSPc) for colonic PDT. The peak concentration of AlSPc in the colon measured by alkali extraction occurred 1 h after i.v. injection. The cellular uptake demonstrated by laser fluorescence microscopy was greater in the mucosa than in the muscle. AlSPc was activated in the tissues by light from an argon ion pumped dye laser at 675 nm. The laser power was set at 100 mW and the fibre placed touching the mucosa. In control animals no macroscopic damage was seen. Temperature measurement using a microthermocouple array showed no temperature rise during light exposure. The energy (fluence), dose of sensitiser and time from sensitisation to phototherapy were altered and the area of necrosis measured. The geometry of the colon made theoretical analysis of the correlation between laser energy and size of lesion difficult. However, following direct measurement of the relative light intensity (fluence rate) in the colon we were able to confirm that there was a threshold fluence for colonic necrosis. The area of photodynamic damage seen 72 h after phototherapy fell with the fall in tissue concentration of AlSPc from 1 h to 1 month after i.v. injection. However, maximum tissue necrosis occurred when treatment was performed immediately after i.v. injection. In this situation, intense vascular spasm was seen and any light transmitted through the colon which fell on the small bowel mesentery caused a lethal ischaemic necrosis. The initial histological changes after PDT were vascular, followed by full thickness necrosis at 72 h. Healing by regeneration was complete by 2-3 weeks. Despite full thickness necrosis there was no reduction in the colonic bursting pressure at any time. Colon treated by hyperthermia had a reduced bursting pressure. Specific collagen stains showed that PDT did not alter the submucosal collagen architecture whereas hyperthermia did.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3663462      PMCID: PMC2002142          DOI: 10.1038/bjc.1987.166

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Thermal considerations in murine tumor killing using hematoporphyrin derivative phototherapy.

Authors:  J H Kinsey; D A Cortese; H B Neel
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

2.  Histopathological comparison of the effects of hematoporphyrin derivative on two different murine tumors using computer-enhanced digital video fluorescence microscopy.

Authors:  J S Nelson; W H Wright; M W Berns
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

3.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor.

Authors:  K R Weishaupt; C J Gomer; T J Dougherty
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

4.  Jejunal blood flow after exposure to light in rats injected with hematoporphyrin derivative.

Authors:  S H Selman; M Kreimer-Birnbaum; P J Goldblatt; T S Anderson; R W Keck; S L Britton
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

5.  Uptake of hematoporphyrin derivative and sensitized photoinactivation of C3H cells with different oncogenic potential.

Authors:  J Moan; H B Steen; K Feren; T Christensen
Journal:  Cancer Lett       Date:  1981-12       Impact factor: 8.679

6.  Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers.

Authors:  W M Star; H P Marijnissen; A E van den Berg-Blok; J A Versteeg; K A Franken; H S Reinhold
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

7.  Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy.

Authors:  B W Henderson; S M Waldow; T S Mang; W R Potter; P B Malone; T J Dougherty
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

8.  Cell uptake, distribution and response to aluminium chloro sulphonated phthalocyanine, a potential anti-tumour photosensitizer.

Authors:  W S Chan; R Svensen; D Phillips; I R Hart
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

9.  Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma.

Authors:  C J Tralau; A J MacRobert; P D Coleridge-Smith; H Barr; S G Bown
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

10.  Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action.

Authors:  M C Berenbaum; G W Hall; A D Hoyes
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

View more
  15 in total

Review 1.  Current concepts in gastrointestinal photodynamic therapy.

Authors:  J Webber; M Herman; D Kessel; D Fromm
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

2.  Local eradication of rat colon cancer with photodynamic therapy: correlation of distribution of photosensitiser with biological effects in normal and tumour tissue.

Authors:  H Barr; P Chatlani; C J Tralau; A J MacRobert; P B Boulos; S G Bown
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

Review 3.  Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling.

Authors:  Nazareth Milagros Carigga Gutierrez; Núria Pujol-Solé; Qendresa Arifi; Jean-Luc Coll; Tristan le Clainche; Mans Broekgaarden
Journal:  Cancer Metastasis Rev       Date:  2022-09-26       Impact factor: 9.237

4.  Laser therapy in the management of benign and malignant tumours in the colon and rectum.

Authors:  N Krasner
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

5.  Experimental studies to assess the potential of photodynamic therapy for the treatment of bronchial carcinomas.

Authors:  S G Smith; J Bedwell; A J MacRobert; M H Griffiths; S G Bown; M R Hetzel
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

6.  Mucosal ablation using photodynamic therapy for the treatment of dysplasia: an experimental study in the normal rat stomach.

Authors:  C S Loh; A J MacRobert; G Buonaccorsi; N Krasner; S G Bown
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

7.  The significance of the nature of the photosensitizer for photodynamic therapy: quantitative and biological studies in the colon.

Authors:  H Barr; A J MacRobert; C J Tralau; P B Boulos; S G Bown
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

8.  Vascular function and the probability of skin necrosis after photodynamic therapy: an experimental study.

Authors:  K Benstead; J V Moore
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

9.  Therapeutic ratio of photodynamic therapy in the treatment of superficial tumours of skin and subcutaneous tissues in man.

Authors:  D Gilson; D Ash; I Driver; J W Feather; S Brown
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

10.  Interstitial photodynamic therapy. Clinical experience with diffusing fibres in the treatment of cutaneous and subcutaneous tumours.

Authors:  C P Lowdell; D V Ash; I Driver; S B Brown
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.